Dr. Daley’s new role will be effective Jan. 1. The previous dean, Jeffrey Flier, MD, stepped down in July. Barbara McNeil, MD, PhD, has been serving as interim dean.
Since 2010, Dr. Daley has been a professor of biological chemistry and molecular pharmacology at Harvard Medical School. In addition, he is the director of the Stem Cell Transplantation Program at Boston Children’s Hospital and Boston-based Dana-Farber Cancer Institute.
“I feel humbled by the prospect of leading so talented a community with so essential a mission — a community whose dynamism, growing diversity and shared concern for the well-being of others are a deep source of strength,” Dr. Daley said in a statement.
More articles on medical schools:
Nevada medical school rolls out new name, branding
Hundreds of Hopkins, Georgetown med students petition to remove $1275 exam
UIW inches closer to opening medical school
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
